—

Orion Oyj A (ORNAV.HE) — Technical state

As of 2026-11-03 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Closelooknet score: 63 out of 100 (momentum 92 · quality 84 · valuation 29), as of 2026-11-04.
  • Signal: Uptrend stack intact — Trades +17.3% vs the 50-day and +32.8% vs the 200-day average, 1.6% below the 52-week high and +77.9% off the 52-week low. Computed from daily closes. (as of 2026-11-03)
  • Trend: Orion Oyj A trades 17.3% above its 50-day and 32.8% above its 200-day moving average. (as of 2026-11-03)

Orion Oyj develops, makes and markets prescription medicines, active pharmaceutical ingredients and veterinary drugs, and sells self-care products such as vitamins and skincare. Its prescription range spans prostate cancer, Parkinson's disease, asthma and COPD inhalers, pain relief and menopausal treatments, sold across Finland, Scandinavia and wider international markets.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the ORNAV.HE overview. Agents can buy the score depth per call over HTTP 402 — see the catalogue. Research diary readings, not advice.

Uptrend stack intact

Trades +17.3% vs the 50-day and +32.8% vs the 200-day average, 1.6% below the 52-week high and +77.9% off the 52-week low. Computed from daily closes.

The moving-average stack

FAQ · from the current data · as of 2026-11-03

Quick answers

What is the current Closelooknet signal on ORNAV.HE?

Uptrend stack intact — Trades +17.3% vs the 50-day and +32.8% vs the 200-day average, 1.6% below the 52-week high and +77.9% off the 52-week low. Computed from daily closes. As of 2026-11-03; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is ORNAV.HE above its 50-day and 200-day moving averages?

As of 2026-11-03, Orion Oyj A trades +17.3% above its 50-day and +32.8% above its 200-day average, with the 20-day +10.1% away.

How far is ORNAV.HE from its 52-week high?

1.6% below the 52-week high and 77.9% above the 52-week low, as of 2026-11-03.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.